Alpha-mangostin reduces cell viability in sorafenib-surviving cells by modulating multiple drug transporters in HepG2 hepatocellular carcinoma cells
Vincent Kharisma Wangsaputra, Syarinta Adenina, Melva Louisa
DOI: 10.7324/JAPS.2021.110612Pages: 105-110
Sorafenib combination with imatinib enhances apoptotic and cell cycle arrest effects with no effect on viability and BCR-ABL expression of K-562 cells
Belal A. Al-Husein, Ahmad Al-Azayzih, Fatema S. Redha
DOI: 10.7324/JAPS.2024.161424Pages:
